Propanc Biopharma Stock Fundamentals
Propanc Biopharma fundamentals help investors to digest information that contributes to Propanc Biopharma's financial success or failures. It also enables traders to predict the movement of Propanc Pink Sheet. The fundamental analysis module provides a way to measure Propanc Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Propanc Biopharma pink sheet.
Propanc |
Propanc Biopharma Company Current Valuation Analysis
Propanc Biopharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Propanc Biopharma Current Valuation | 1.32 M |
Most of Propanc Biopharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Propanc Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Propanc Biopharma has a Current Valuation of 1.32 M. This is 99.99% lower than that of the Healthcare sector and 99.97% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Propanc Biopharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Propanc Biopharma's current stock value. Our valuation model uses many indicators to compare Propanc Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Propanc Biopharma competition to find correlations between indicators driving Propanc Biopharma's intrinsic value. More Info.Propanc Biopharma is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 0.52 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Propanc Biopharma is roughly 1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Propanc Biopharma's earnings, one of the primary drivers of an investment's value.Propanc Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Propanc Biopharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Propanc Biopharma could also be used in its relative valuation, which is a method of valuing Propanc Biopharma by comparing valuation metrics of similar companies.Propanc Biopharma is currently under evaluation in current valuation category among its peers.
Propanc Fundamentals
| Current Valuation | 1.32 M | |||
| Shares Outstanding | 691.17 K | |||
| Shares Owned By Insiders | 1.94 % | |||
| Shares Owned By Institutions | 1.94 % | |||
| EBITDA | (2.97 M) | |||
| Net Income | (3.67 M) | |||
| Cash And Equivalents | 51.22 K | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 1.1 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (4.44) X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | (16.63) X | |||
| Beta | 2.05 | |||
| Market Capitalization | 259.19 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Propanc Pink Sheet
If you are still planning to invest in Propanc Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Propanc Biopharma's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |